2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-benzooxazole

ID: ALA168978

PubChem CID: 44380086

Max Phase: Preclinical

Molecular Formula: C15H11NO3

Molecular Weight: 253.26

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc2c(c1)OCC(c1nc3ccccc3o1)O2

Standard InChI:  InChI=1S/C15H11NO3/c1-2-6-11-10(5-1)16-15(19-11)14-9-17-12-7-3-4-8-13(12)18-14/h1-8,14H,9H2

Standard InChI Key:  CWCFMJLMWLEGKJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 22  0  0  0  0  0  0  0  0999 V2000
    6.2625   -3.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3417   -2.7167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5417   -3.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0125   -3.8792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8250   -3.5292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1500   -2.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8250   -5.1917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5625   -3.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1125   -3.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5417   -4.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1125   -4.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5625   -1.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3792   -3.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4000   -3.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4000   -5.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8000   -2.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3875   -1.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6875   -3.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6875   -4.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  1  1  0
  5  3  1  0
  6  2  1  0
  7 10  1  0
  8  4  1  0
  9  5  1  0
 10  3  1  0
 11  7  1  0
 12  6  1  0
 13  8  1  0
 14  9  2  0
 15 11  2  0
 16 13  2  0
 17 12  2  0
 18 14  1  0
 19 15  1  0
  6  8  2  0
  9 11  1  0
 16 17  1  0
 19 18  2  0
M  END

Alternative Forms

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 253.26Molecular Weight (Monoisotopic): 253.0739AlogP: 3.34#Rotatable Bonds: 1
Polar Surface Area: 44.49Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.84CX LogD: 2.84
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.67Np Likeness Score: -0.50

References

1. Chapleo CB, Myers PL, Butler RC, Doxey JC, Roach AG, Smith CF..  (1983)  alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants.,  26  (6): [PMID:6133953] [10.1021/jm00360a008]

Source